BMO Capital Reiterates Outperform on Johnson & Johnson (JNJ) Following 2Q Report
Tweet Send to a Friend
BMO Capital reiterated an Outperform rating and $132.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's 2Q ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
